# Vitalant – FDA Inspection, Aug 9, 2023

Source: https://www.keypedia.com/records/fda_inspections/vitalant/c66b5bca-9e2f-4761-9095-f71cc97c5588
Source feed: FDA_Inspections

> FDA inspection 1214538 of Vitalant, August 09, 2023. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1214538
- Company Name: Vitalant
- Inspection Date: 2023-08-09
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1098166 - 2019-07-18
- FDA Inspection 984109 - 2016-08-18
- [FDA Inspection 895712 - 2014-09-12](https://www.keypedia.com/records/fda_inspections/vitalant/1251444f-4c62-4139-9739-a79907aba556)
- FDA Inspection 789482 - 2012-06-22
- FDA Inspection 604009 - 2009-08-04

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/shelley-h-beausoleil/1212116b-e24d-4bbc-a27a-5c16334d573e)

Company: https://www.keypedia.com/companies/vitalant/250dac73-2d2c-4243-8c5b-2e2e387ea86c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d